Tissue Diagnostics Market Set for Rapid Growth by 2030
Tissue Diagnostics Market Overview
Tissues is a group of human cells that play a vital role in performing various biological functions that are important for other healthy functions in a human body.
As these layers of cells carry extremely important elements of information about the health prospects of the body, tissue samples are commonly taken to analyse and diagnose various health conditions, as they capture the biological specification of any disease.
Tissue diagnostics is emerging as an important field of diagnostics research as tissue samples can explain various aspects of different biological conditions. Especially in the field of cancer diagnostics and analysis, tissue diagnostics have played a key role as it has helped scientists and researchers identify the presence of cancer upon examining the tissue samples.
Tissue diagnostics is also gaining immense popularity in the other diagnostics areas where origin and treatment of different other chronic diseases are being studied by leading pharmaceutical companies.
Histopathology is among the most commonly implemented methods of tissue diagnostics, and it involves the analysis with tissue samples through various processes such as fine needle aspiration cytology, small biopsies, and open biopsy or surgery.
Other important types of tissue diagnostics are in situ hybridization, Immunohistochemistry (IHC), and Hematoxylin and Eosin (H&E). Based on the tissue samples under observation, the motive of the diagnostics, and other specific conditions, the method of tissue diagnostics is decided.
Advent of Digital Pathologies to Transform the Modern Tissue Diagnostics Landscape
Diagnostic laboratories or pathologies have worked on the traditional model for years, where microscopes have been the go-t0 instrument for pathologists worldwide. However, the rise of digitalization across the entire healthcare industry is triggering the adoption of modern technologies that can digitally transform conventional models of pathologies.
A majority of healthcare businesses are entering the digital era with the establishment of new digital pathology systems that are equipped with the network of high-definition tissue diagnostics instruments.
For more insights into the market, request a sample of this report@
The modern diagnostics laboratories are shifting from the traditional devices for studying and examining magnified tissue samples to diagnose different health conditions to more modern and high-tech instruments in the innovative diagnostics environment called digital pathologies.
The adoption of whole-slide imaging (WSI) among various other tech-driven diagnostic tools is on the rise, and this has defined an emerging trend in the digital pathology set up.
Leading players in the tissue diagnostics market are realising this shift in the operational models of pathologies and diagnostic laboratories to modify their offerings and features of their services.
In the coming years, the rise of digital pathologies will become more prevalent, triggering all the stakeholders in the tissue diagnostics market to acquire advanced technologies to offer the new-age tissue diagnostics products in the coming years.
Ongoing Research in the Diagnostics of Cancer will Primarily Boost Demand
Growing prevalence of cancer across the world has triggered a significant rise in the research & development activities in the tissue diagnostics field. With over 18 million new cases and more than 9.6 million deaths due to cancer, the global cancer burden increased alarmingly in 2018, according to the World Health Organization (WHO).
The global tissue diagnostics market is expected to witness rising collaborations between research institutions and market players in the area of cancer research.
For instance, in June 2020, the University of Sheffield, United Kingdom, inked its collaboration with Zilico Ltd – a UK-based company which specialises in the design and manufacture of real-time medical diagnostics to address specific clinical needs – to invent a non-invasive, pain-free, and instantaneous method to diagnose oral cancer with the implementation of its electrical impedance spectroscopy (EIS) technology.
In the same month, Epredia – a global leader in precision cancer diagnostics and tissue diagnostics, announced that it is entering a strategic distribution agreement with Lunaphore Technologies SA – a Swiss life-sciences company that specialised in the development of innovative next-generation equipment for cancer research.
Lunaphore is a leading supplier and manufacturer of tissue staining instruments, and it will integrate Fast Fluidic Exchange microfluidic technology with its tissue diagnostics instruments for uniform and rapid delivery of reagents to tissue samples through rapid immunohistochemistry (IHC) and immunofluorescence (IF).
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
